KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Return on Capital Employed: 2013-2025

Historic Return on Capital Employed for Sarepta Therapeutics (SRPT) over the last 11 years, with Jun 2025 value amounting to -0.04%.

  • Sarepta Therapeutics' Return on Capital Employed fell 6.00% to -0.04% in Q2 2025 from the same period last year, while for Jun 2025 it was -0.04%, marking a year-over-year decrease of 6.00%. This contributed to the annual value of 0.08% for FY2024, which is 18.00% up from last year.
  • Per Sarepta Therapeutics' latest filing, its Return on Capital Employed stood at -0.04% for Q2 2025, which was down 161.79% from 0.07% recorded in Q4 2024.
  • Over the past 5 years, Sarepta Therapeutics' Return on Capital Employed peaked at 0.07% during Q4 2024, and registered a low of -0.27% during Q2 2021.
  • Moreover, its 3-year median value for Return on Capital Employed was -0.04% (2025), whereas its average is -0.07%.
  • In the last 5 years, Sarepta Therapeutics' Return on Capital Employed decreased by 8bps in 2023 and then climbed by 21bps in 2024.
  • Over the past 5 years, Sarepta Therapeutics' Return on Capital Employed (Quarterly) stood at -0.19% in 2021, then dropped by 3bps to -0.21% in 2022, then increased by 11bps to -0.11% in 2023, then grew by 18bps to 0.07% in 2024, then decreased by 6bps to -0.04% in 2025.
  • Its last three reported values are -0.04% in Q2 2025, 0.07% for Q4 2024, and 0.03% during Q3 2024.